These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11581191)

  • 1. Inhibition of inflammatory corneal angiogenesis by TNP-470.
    Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
    J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.
    Lund EL; Bastholm L; Kristjansen PE
    Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor.
    Yoshida A; Anand-Apte B; Zetter BR
    Growth Factors; 1996; 13(1-2):57-64. PubMed ID: 8962720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
    Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
    Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
    Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
    Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
    Ishida K; Yoshimura N; Mandai M; Honda Y
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
    Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer].
    Fan YF; Huang ZH; Nie J
    Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
    Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Anticancer Res; 2000; 20(1C):601-4. PubMed ID: 10769702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.
    Udagawa T; Yuan J; Panigrahy D; Chang YH; Shah J; D'Amato RJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):421-7. PubMed ID: 10900214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin is an in vivo inhibitor of angiogenesis.
    Arbiser JL; Klauber N; Rohan R; van Leeuwen R; Huang MT; Fisher C; Flynn E; Byers HR
    Mol Med; 1998 Jun; 4(6):376-83. PubMed ID: 10780880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.